MorphoSys To Get Clinical Trial Milestone Payment From Centocor Ortho
As part of the Centocor Ortho Biotech collaboration in 2007, a HuCAL antibody became the first from MorphoSys to be developed in two different therapeutic areas – oncology
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.
Quotient Bioresearch’s The Old Glassworks is expected to produce radiolabelled compounds for use in both pre-clinical and clinical settings, for its pharmaceutical, biotechnology and agrochemical clients, offering a